C the Signs™ is a validated AI cancer detection platform with 99% sensitivity, identifying patients at the earliest, most survivable stages. Partnered with 1,400 GP practices, it has detected over 25,000 cases across 50 cancer types.

This session will explore how implementing clinical decision support systems can enhance cancer outcomes in primary care, improve safety, and help practices meet QOF, DES, and IIF targets, optimising patient care and earlier detection.